Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
Stanford University |
---|---|
Information provided by: | Stanford University |
ClinicalTrials.gov Identifier: | NCT00802984 |
The purpose of this study is to determine whether the system is safe and effective for the intended use of treating descending thoracic aortic aneurysms.
Condition | Intervention | Phase |
---|---|---|
Aortic Aneurysm, Thoracic |
Device: Endovascular thoracic aortic aneurysm repair using TALENT TAA Stent Graft System |
Phase IV |
Study Type: | Interventional |
Study Design: | Treatment, Non-Randomized, Open Label, Uncontrolled, Single Group Assignment, Safety/Efficacy Study |
Official Title: | Endovascular Treatment of Thoracic Aortic Aneurysms Using the TALENT Stent Graft System |
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Patient has one or more of the following:
Exclusion Criteria:
United States, California | |
Stanford University School of Medicine | |
Stanford, California, United States, 94305 |
Principal Investigator: | Christopher K Zarins MD | Stanford University |
Study ID Numbers: | SU-11092007-868, IRB Protocol Number 77836 |
Study First Received: | December 4, 2007 |
Last Updated: | December 12, 2008 |
ClinicalTrials.gov Identifier: | NCT00802984 |
Health Authority: | United States: Food and Drug Administration; USA:External Monitoring Entity |
Aortic Diseases Aortic Aneurysm, Thoracic Aneurysm Vascular Diseases Aortic Aneurysm |
Cardiovascular Diseases |